Physician profile
Ivan Urits
NPI 1346635422
$69,649.32
in general payments reported to CMS, 2019-2025
35 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,173 · 2021: $13K · 2022: $21K · 2023: $7,489 · 2024: $5,081 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $11K · Travel and Lodging: $5,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,962.50 |
| Food and Beverage | $10,858.17 |
| Travel and Lodging | $5,115.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29,984.92 | 2020-2025 | Wavewriter Alpha Prime 16, Sidekick 2, Superion Indirect Decompression System |
| Vertex Pharmaceuticals Incorporated | $16,700.63 | 2025 | |
| Mml US, INC. | $3,102.99 | 2021-2023 | Reactiv8 |
| Nevro Corp. | $2,986.47 | 2020-2024 | Senza |
| Medtronic, INC. | $2,748.50 | 2022-2025 | Venaseal, Intellis Adaptivestim, Inceptiv |
| Painteq LLC | $2,500.81 | 2021-2024 | Painteq |
| Saluda Medical Americas, INC. | $1,679.50 | 2023-2024 | Evoke Scs, Evoke |
| Abbott Laboratories | $1,436.09 | 2020-2024 | Proclaim, Octrode |
| Nalu Medical, INC. | $1,280.81 | 2021-2025 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $1,071.31 | 2024 | Ha Minuteman G3-R, Liberty Si |
| Pacira Pharmaceuticals Incorporated | $814.73 | 2022 | |
| Abbvie INC. | $732.77 | 2022-2025 | Ubrelvy, Qulipta |
| Stryker Corporation | $688.10 | 2025 | Spinejack, Mild Device Kit |
| Stimwave Technologies Incorporated | $522.81 | 2020-2022 | |
| Vertos Medical, INC. | $451.47 | 2020-2024 | Mild Device Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $389.47 | 2020-2023 | Sprint Pns System |
| Globus Medical, INC. | $357.70 | 2025 | Senza, Vyrsa V1 |
| Biotronik Nro, INC. | $324.22 | 2024-2025 | Prospera |
| Valinor Pharma, LLC | $303.75 | 2023-2025 | Movantik |
| Curonix LLC | $254.96 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceuticals, INC. | $226.10 | 2020-2021 | |
| Pfizer INC. | $211.56 | 2020-2025 | |
| Lilly USA, LLC | $172.54 | 2023-2025 | Emgality, Reyvow |
| Biohaven Pharmaceutical Holding Company Ltd. | $154.45 | 2022 | |
| Medtronic USA, INC. | $144.16 | 2020 | |
| Cala Health, INC. | $116.87 | 2022 | |
| Relievant Medsystems, INC. | $99.60 | 2021 | |
| Biodelivery Sciences International, INC. | $34.81 | 2021 | |
| Spinefrontier, INC. | $32.31 | 2020 | |
| Eisai INC. | $30.87 | 2025 | |
| Livanova USA, INC. | $27.08 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Acadia Pharmaceuticals INC | $24.03 | 2024 | Daybue |
| Alexion Pharmaceuticals, INC. | $21.13 | 2023 | Ultomiris |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.30 | 2024 | Relistor |
| Grt US Holding, INC. | $8.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Urits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.